Why Johnson & Johnson Is Eyeing Protagonist Therapeutics: The Rationale

2025-10-13 10:09:05 ET

Thesis

It's been a busy week for Protagonist Therapeutics, Inc. (PGTX) in terms of news. They're a name that wouldn't have been on everyone's map before the interest shown by Johnson & Johnson ( JNJ ) ("J&J"); however, after last week, their stock has seen significant upside. Shares are now trading in the $80 range and have seen a 30% jump as a result of the news....

Read the full article on Seeking Alpha

For further details see: